Ra Pharma® is a clinical-stage biopharmaceutical company using a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system, a critical component of the immune system.


Copyright West LLC. Minimum 15 minutes delayed.

Recent News
Ra Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
Read More
Dosing completed in Phase 2 trial of zilucoplan in generalized myasthenia gravis On track for topline data read-out around year-end 2018 Announces issuance of U.S. patent covering zilucoplan composition of matter and methods of use CAMBRIDGE, Mass. --(BUSINESS WIRE)--Nov.

Contact Us

Ra Pharmaceuticals, Inc.
87 Cambridge Park Drive
Cambridge, MA 02140
Phone: (617) 401-4060
Fax: (617) 401-4061